These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29788340)

  • 1. Utilizing Nurses to Staff an Ebola Vaccine Clinical Trial in Sierra Leone during the Ebola Outbreak.
    Edem-Hotah J; McDonald W; Abu PM; Luman ET; Carter RJ; Koker A; Goldstein ST
    J Infect Dis; 2018 May; 217(suppl_1):S60-S64. PubMed ID: 29788340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.
    Jusu MO; Glauser G; Seward JF; Bawoh M; Tempel J; Friend M; Littlefield D; Lahai M; Jalloh HM; Sesay AB; Caulker AF; Samai M; Thomas V; Farrell N; Widdowson MA
    J Infect Dis; 2018 May; 217(suppl_1):S48-S55. PubMed ID: 29788339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience.
    Kabineh AK; Carr W; Motevalli M; Legardy-Williams J; Vincent W; Mahon BE; Samai M
    J Infect Dis; 2018 May; 217(suppl_1):S56-S59. PubMed ID: 29788349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    Carter RJ; Senesi RGB; Dawson P; Gassama I; Kargbo SAS; Petrie CR; Rogers MH; Samai M; Luman ET
    J Infect Dis; 2018 May; 217(suppl_1):S65-S74. PubMed ID: 29788348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.
    Conteh MA; Goldstein ST; Wurie HR; Gidudu J; Lisk DR; Carter RJ; Seward JF; Hampton LM; Wang D; Andersen LE; Arvay M; Schrag SJ; Dawson P; Fombah AE; Petrie CR; Feikin DR; Russell JBW; Lindblad R; Kargbo SAS; Samai M; Mahon BE
    J Infect Dis; 2018 May; 217(suppl_1):S33-S39. PubMed ID: 29788347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
    Carter RJ; Idriss A; Widdowson MA; Samai M; Schrag SJ; Legardy-Williams JK; Estivariz CF; Callis A; Carr W; Webber W; Fischer ME; Hadler S; Sahr F; Thompson M; Greby SM; Edem-Hotah J; Momoh RM; McDonald W; Gee JM; Kallon AF; Spencer-Walters D; Bresee JS; Cohn A; Hersey S; Gibson L; Schuchat A; Seward JF
    J Infect Dis; 2018 May; 217(suppl_1):S16-S23. PubMed ID: 29788343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.
    Samai M; Seward JF; Goldstein ST; Mahon BE; Lisk DR; Widdowson MA; Jalloh MI; Schrag SJ; Idriss A; Carter RJ; Dawson P; Kargbo SAS; Leigh B; Bawoh M; Legardy-Williams J; Deen G; Carr W; Callis A; Lindblad R; Russell JBW; Petrie CR; Fombah AE; Kargbo B; McDonald W; Jarrett OD; Walker RE; Gargiullo P; Bash-Taqi D; Gibson L; Fofanah AB; Schuchat A;
    J Infect Dis; 2018 May; 217(suppl_1):S6-S15. PubMed ID: 29788345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.
    Jarrett OD; Seward JF; Fombah AE; Lindblad R; Jalloh MI; El-Khorazaty J; Dawson P; Burton D; Zucker J; Carr W; Bah MM; Deen GF; George PM; James F; Lisk DR; Pratt D; Russell JBW; Sandy JD; Turay P; Hamel MJ; Schrag SJ; Walker RE; Samai M; Goldstein ST
    J Infect Dis; 2018 May; 217(suppl_1):S24-S32. PubMed ID: 29788346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons Learned in Clinical Trial Communication During an Ebola Outbreak: The Implementation of STRIVE.
    Callis A; Carter VM; Ramakrishnan A; Albert AP; Conteh L; Barrie AA; Fahnbulleh L; Koroma MM; Saidu S; Williams O; Samai M
    J Infect Dis; 2018 May; 217(suppl_1):S40-S47. PubMed ID: 29788341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    Fombah AE; Goldstein ST; Jarrett OD; Jalloh MI; El-Khorazaty J; Lisk DR; Legardy-Williams J; Pratt DA; George PM; Russell JBW; Schrag SJ; Dawson P; Deen GF; Carr W; Lindblad R; James F; Bah MM; Yillia JF; Sandy JD; Turay PE; Conteh MA; Slutsker L; Mahon BE; Samai M; Seward JF
    J Infect Dis; 2018 May; 217(suppl_1):S75-S80. PubMed ID: 29788342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions and acceptability of an experimental Ebola vaccine among health care workers, frontline staff, and the general public during the 2014-2015 Ebola outbreak in Sierra Leone.
    Jalloh MF; Jalloh MB; Albert A; Wolff B; Callis A; Ramakrishnan A; Cramer E; Sengeh P; Pratt SA; Conteh L; Hajjeh R; Bunnell R; Redd JT; Ekström AM; Nordenstedt H
    Vaccine; 2019 Mar; 37(11):1495-1502. PubMed ID: 30755367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    Schuchat A; Seward JF; Goldstein ST; Mahon BE
    J Infect Dis; 2018 May; 217(suppl_1):S1-S5. PubMed ID: 29788344
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementing an Ebola Vaccine Study - Sierra Leone.
    Widdowson MA; Schrag SJ; Carter RJ; Carr W; Legardy-Williams J; Gibson L; Lisk DR; Jalloh MI; Bash-Taqi DA; Kargbo SA; Idriss A; Deen GF; Russell JB; McDonald W; Albert AP; Basket M; Callis A; Carter VM; Ogunsanya KR; Gee J; Pinner R; Mahon BE; Goldstein ST; Seward JF; Samai M; Schuchat A
    MMWR Suppl; 2016 Jul; 65(3):98-106. PubMed ID: 27387395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from engaging communities for Ebola vaccine trials in Sierra Leone: reciprocity, relatability, relationships and respect (the four R's).
    Dada S; McKay G; Mateus A; Lees S
    BMC Public Health; 2019 Dec; 19(1):1665. PubMed ID: 31829223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola vaccine? Family first! Evidence from using a brief measure on Ebola vaccine demand in a national household survey during the outbreak in Sierra Leone.
    Jalloh MF; Wallace AS; Bunnell RE; Carter RJ; Redd JT; Nur SA; Zeebari Z; Ekström AM; Nordenstedt H
    Vaccine; 2020 May; 38(22):3854-3861. PubMed ID: 32291102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious Diseases. Ebola vaccine trials raise ethical issues.
    Cohen J; Kupferschmidt K
    Science; 2014 Oct; 346(6207):289-90. PubMed ID: 25324364
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Zhu FC; Wurie AH; Hou LH; Liang Q; Li YH; Russell JB; Wu SP; Li JX; Hu YM; Guo Q; Xu WB; Wurie AR; Wang WJ; Zhang Z; Yin WJ; Ghazzawi M; Zhang X; Duan L; Wang JZ; Chen W
    Lancet; 2017 Feb; 389(10069):621-628. PubMed ID: 28017399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control of Ebola hemorrhagic fever: vaccine development and our Ebola project in Sierra Leone].
    Watanabe T; Kawaoka Y
    Uirusu; 2016; 66(1):53-62. PubMed ID: 28484179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone.
    Camacho A; Eggo RM; Goeyvaerts N; Vandebosch A; Mogg R; Funk S; Kucharski AJ; Watson CH; Vangeneugden T; Edmunds WJ
    Vaccine; 2017 Jan; 35(4):544-551. PubMed ID: 28024952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model.
    Diakite I; Mooring EQ; Velásquez GE; Murray MB
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004866. PubMed ID: 27509037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.